Bio-Techne Corp (TECH)

The payables turnover ratio for Bio-Techne Corp demonstrates notable fluctuations over the examined fiscal periods. As of June 30, 2021, the ratio was recorded at 10.15, indicating the company paid its average accounts payable approximately 10.15 times during that fiscal year. This ratio experienced a slight increase in the subsequent year, reaching 10.31 as of June 30, 2022, suggesting a marginal acceleration in the company's payment cycle or possibly improved liquidity management.

A more pronounced change occurred by June 30, 2023, when the payables turnover ratio rose to 14.29. This increase reflects a significant reduction in the average number of days the company takes to settle its payables, implying a more aggressive payment approach, enhanced liquidity position, or favorable supplier terms during this period.

However, the ratio declined again in the fiscal year ending June 30, 2024, decreasing to 10.25. This suggests a slight elongation of the payment cycle compared to the prior year, possibly indicating shifts in supplier negotiations, cash flow considerations, or operational adjustments.

Looking forward to June 30, 2025, the payables turnover ratio markedly increased to 16.96, reaching the highest level observed within the analyzed timeframe. This substantial rise indicates that Bio-Techne Corp paid its suppliers at a much faster rate relative to the previous periods, potentially reflecting improved liquidity, strategic supplier relationship management, or a focus on reducing outstanding payables to enhance supplier trust and credit terms.

Overall, the trend indicates that the company's payables management has become increasingly efficient over the years, culminating in a notably higher ratio by mid-2025. Such a trend suggests a strategic emphasis on timely payments, which could positively influence supplier relationships and creditworthiness, or alternatively, reflect better cash flow availability.

Peer comparison

Jun 30, 2025